Lantheus Holdings (LNTH) said Tuesday it has closed the purchase of Evergreen Theragnostics with a cash payment of $275 million.
The consideration comprised an upfront payment of $250 million and a $25 million milestone payment, the company said.
Lantheus Holdings (LNTH) said Tuesday it has closed the purchase of Evergreen Theragnostics with a cash payment of $275 million.
The consideration comprised an upfront payment of $250 million and a $25 million milestone payment, the company said.
Comments